Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
A more comprehensive approach would be to concurrently measure actual protein levels (e.g., WB, ELISA, etc.) of potential targets in addition to inhibitor assays
1 The global anti-obesity drug market is expected to reach $82.55 billion (USD) by 2032, driven by a compound annual growth rate (CAGR) of 18.01% from 2025 to 2032
65 In a meta-analysis by He et al, which included 76 RCTs covering more than 100,000 overweight or obese individuals, GLP-1 RA use was reported to increase the risk of gallbladder stones or biliary tract disease by 37% (RR 1.37 [95% CI 1.231.52])
Do not assume the peptide is compromised without testing, but do not assume it remains viable either
US$ 20.25
US$ 28.15
US$ 26.07
US$ 26.56
US$ 22.15
US$ 26.16
US$ 20.38
